Bayforest Capital’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.81K Sell
54
-100
-65% -$5.4K ﹤0.01% 871
2026
Q1
$8.05K Buy
154
+119
+340% +$7.14K 0.01% 812
2025
Q4
$2.06K Sell
35
-7,477
-100% -$454K ﹤0.01% 743
2025
Q3
$418K Buy
7,512
+2,884
+62% +$154K 0.2% 188
2025
Q2
$238K Buy
4,628
+56
+1% +$2.81K 0.1% 344
2025
Q1
$268K Buy
+4,572
New +$310K 0.12% 328

Other funds holding TECH

Bayforest Capital's TECH Position: Q2 2026 in Review

Bayforest Capital reduced its Bio-Techne (TECH) stake by 65% in Q2 2026, selling an estimated $5.4K and leaving 54 shares worth $3.81K. The position accounts for ﹤0.01% of the portfolio, ranked #871.

Bayforest Capital first reported a position in TECH in Q1 2025 and has held it in 6 quarters since. The position peaked at $418K in Q3 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Bayforest Capital held 54 shares of Bio-Techne worth $3.81K as of Q2 2026.
  • Bayforest Capital sold 100 Bio-Techne shares in Q2 2026, an estimated $5.4K.
  • Bio-Techne made up ﹤0.01% of Bayforest Capital's portfolio in Q2 2026, its #871 holding.
  • Bayforest Capital first reported a position in Bio-Techne in Q1 2025 and has held it in 6 quarters since.
  • Bayforest Capital's Bio-Techne position peaked at $418K in Q3 2025.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.